[1]
Krasiuk Е., Grigorieva Є. and Semeryk Ю. 2021. CONTROL OF SECONDARY HYPERPARATIREOSIS BY INTRAVENOUS INTRODUCTION OF PARSABIV IN PATIENTS WITH CHRONIC KIDNEY DISEASE V D STAGE IN HEMODIALYSIS. Actual Problems of Nephrology. 29 (Dec. 2021), 51–57. DOI:https://doi.org/10.37321/nefrology.2021.29-05.